Wockhardt Ltd — Major Shareholding Notification 2022

Apr 1, 2022

31[st] March, 2021

BSE Limited National Stock Exchange of India Limited Corporate Relations Department Exchange Plaza P J Towers, Bandra Kurla Complex, Dalal Street Bandra (E), Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 532300 NSE Symbol: WOCKPHARMA

Dear Sirs,

Sub: Disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations. 2011 [‘SEBI (SAST) Regulations’].

Please find enclosed the disclosure under regulation 10(6) of the SEBI (SAST) Regulations in respect of shares acquired by the members of the Promoter and Promoter Group of the Company pursuant to the Rights Issue of the Company.

In this regard, we clarify that the members of Promoters and Promoter Group of the Company have acquired additional shares pursuant to the Rights Issue (which was fully subscribed) only to the extent of their entitlement i.e. 2,23,18,601 shares and accordingly there is no change in total voting power or percentage holding of the Promoter and Members of Promoter Group consequent to the aforesaid acquisition.

Accordingly, the provisions of regulation 3(2) of the SEBI (SAST) Regulations is not applicable for the aforementioned transaction. However, this report is being filed voluntarily as a measure of good corporate governance in view of significant number of new shares acquired by the Promoters & Members of Promoter Group.

You are requested to kindly take the same on your records.

Thanking you,

For and on behalf of the Promoters and Members of Promoter Group

==> picture [150 x 44] intentionally omitted <==

Dr. H. F. Khorakiwala Promoter

Encl : As above

CC: Wockhardt Limited D-4, MIDC, Chikalthana, Aurangabad - 431006

Disclosures under Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

==> picture [485 x 593] intentionally omitted <==

----- Start of picture text ----- Name of the Target Company (TC) Wockhardt LimitedName of the Acquiring Entities/IndividualsPromotersIndividualDr. Habil KhorakiwalaPartnership Firm ^Themisto Trustee Company Private Limited (on behalf ofHumuza Consultants)Promoter GroupIndividualDr. Huzaifa KhorakiwalaDr. Murtaza KhorakiwalaMs. Nafisa KhorakiwalaMr. Miqdad KhorakiwalaPartnership Firm ^Ananke Trustee Company Private Limited (on behalf ofName of the acquirer(s)Amalthea Consultants)Callirhoe Trustee Company Private Limited (on behalf ofLysithae Consultants)Pasithee Trustee Company Private Limited (on behalf of HNZConsultants)Trust *Themisto Trustee Company Private Limited (on behalf of HabilKhorakiwala Trust)Ananke Trustee Company Private Limited (on behalf ofAmalthea Discretionary Trust)Callirhoe Trustee Company Private Limited (on behalf ofLysithea Discretionary Trust)Pasithee Trustee Company Private Limited (on behalf of HNZDiscretionary Trust)Name of the stock exchange where shares of the 1. BSE LimitedTC are listed 2. National Stock Exchange of India LimitedDetails of the transaction including rationale, if Rights IssueRelevant regulation under which the acquirer is10(4)(a)exempted from making open offerWhether disclosure of proposed acquisition wasrequired to be made under regulation 10 (5) and ifso,- whether disclosure was made and whether it was Not Applicablemade within the timeline specified under theregulations.- date of filing with the stock exchange.Details of acquisition Disclosures required to be Whether the disclosuresmade under regulation 10(5) under regulation 10(5) areactually madea. Name of the transferor / seller - - - -b. Date of acquisition - - - -Number of shares/ voting rights in respect ofc. the acquisitions from each person- - - -mentioned in 7(a) above----- End of picture text -----**

==> picture [485 x 347] intentionally omitted <==

----- Start of picture text ----- Total shares proposed to be acquired /d. actually acquired as a % of diluted share- - - -capital of TCPrice at which shares are proposed to bee.- - - -acquired / actually acquiredPre-Transaction Post-TransactionShareholding details % w.r.t total % w.r.t totalNo. of shares share No. of shares share capitalheld capital of TC held of TCEach Acquirer / TransfereePartnership Firm *Themisto Trustee Company Private Limited 59,495,957 53.69 77,344,744 53.69Ananke Trustee Company Private Limited 3,200,000 2.89 4,160,000 2.89Callirhoe Trustee Company Private Limited 3,200,000 2.89 4,160,000 2.89Pasithee Trustee Company Private Limited 3,400,000 3.07 4,420,000 3.07Trust *Themisto Trustee Company Private Limited 2,300,000 2.08 2,990,000 2.08Ananke Trustee Company Private Limited 672,716 0.61 874,530 0.61Callirhoe Trustee Company Private Limited 720,578 0.65 936,751 0.65Pasithee Trustee Company Private Limited 500,000 0.45 650,000 0.45Other Promoters and Members of PromoterGroup#Dr. Habil F. Khorakiwala 459,451 0.41 597,286 0.41Dr. Huzaifa H. Khorakiwala 216,000 0.19 280,800 0.19Dr. Murtaza H. Khorakiwala 226,200 0.20 294,060 0.20Mrs. Nafisa H. Khorakiwala 2,640 0.00 3,432 0.00Mr. Miqdad H. Khorakiwala 1,800 0.00 2,340 0.00Total 74,395,342 67.13 96,713,943 67.13Each Seller / Transferor - - - ------ End of picture text -----

Notes:

1. ^ The shares appearing under Category "Partnership Firm" are held by the said Companies in capacity as a Trustee of respective Trusts being partner in Partnership Firms i.e. Humuza Consultants, Amalthea Consultants, Lysithea Consultants and HNZ Consultants respectively.

1. • The shares appearing under Category "Trust" are held by the said Companies in the capacity as a Trustee of Trusts i.e. Habil Khorakiwala Trust, Amalthea Discretionary Trust, Lysithea Discretionary Trust and HNZ Discretionary Trust respectively.

3. # Member of Promoter Group" also includes Ms. Zahabiya Khorakiwala, Dartmour Holdings Private Limited ('DHPL'), Palanpur Holdings and Investments Private Limited ('PHIPL') and Khorakiwala Holdings and Investments Private Limited ('KHIPL'). Ms. Zahabiya Khorakiwala, DHPL, PHIPL and KHIPL currently does not hold any equity share in the Company, however, they form part of Promoter and Promoter Group of the Company with Nil holding.

4. **The above acquistion of 2,23,18,601 equity shares by the Promoters and Members of Promoter Group on 28/03/2022 was by virtue of the Rights Issue to the extent of their entitlement and there is no change in total voting power or percentage holding of the Promoter and Promotere Group due to this acquisition. Accordingly, the provisions of regulation 3(2) of the SEBI (SAST) Regulations is not applicable for the aforementioned transaction. However, this report is being filed voluntarily as a measure of good corporate governance in view of significant number of new shares acquired by the Promoter & Members of Promoter Group.

For and on behalf of the Promoters and Members of Promoter Group

==> picture [127 x 35] intentionally omitted <==

Dr. H. F. Khorakiwala

Promoter Place: Mumbai Date: 31st March, 2022